Evidence map›Paper›PMID 19109162›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection.

Naohiko Fukami, Sabarinathan Ramachandran, Deepti Saini, Michael Walter, William Chapman, G Alexander Patterson, Thalachallour Mohanakumar

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03388008 (A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation), which is not on this map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03388008 phase2completednot on this mapstarted 2019, after this paper: background citation

A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation

TypeinterventionalSponsorWashington University School of MedicineRan2019 to 2022Enrolled27ConditionsLung Transplant Rejection, Antibody-mediated RejectionArmsBelatacept, Tacrolimus, ATG, Mycophenolate Mofetil, Methylprednisolone
3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 154 citations in OpenAlex.

  1. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2010
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. A decline in club cell secretory proteins in lung transplantation is associated with release of natural killer cells exosomes leading to chronic rejection.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2020
    Article
  14. Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  15. Review
  16. Autoantibodies in lung transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2020
    Review
  17. Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Observational
  18. Article
  19. Review
  20. Review

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Naohiko FukamiDepartment of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Sabarinathan Ramachandran
Deepti Saini
Michael Walter
William Chapman
G Alexander Patterson
Thalachallour Mohanakumar
Washington University in St. Louis · US

Funding

PATHOGENESIS OF POST-TRANSPLANT BRONCHIOLITIS OBLITERANSR01HL066452 · NHLBI · WASHINGTON UNIVERSITY · PI MOHANAKUMAR, THALACHALLOUR · 2001 to 2004
$1.2M
Pathogenesis of Post-Transplant Bronchiolitis ObliteransR56HL066452 · NHLBI · WASHINGTON UNIVERSITY · PI MOHANAKUMAR, THALACHALLOUR · 2008 to 2008
$380k
NHLBI NIH HHS HL66452NHLBI NIH HHS R01 HL066452NHLBI NIH HHS R56 HL066452
6 · The paper itself

Abstract

Alloimmunity to mismatched donor HLA-Ags and autoimmunity to self-Ags have been hypothesized to play an important role in immunopathogenesis of chronic rejection of transplanted organs. However, it is not known what role, if any, alloimmune response plays in inducing autoimmunity. To test whether Ab-developed posttransplantation to mismatched donor MHC induces autoimmunity and chronic rejection, we developed a murine model wherein anti-MHC class I Abs or control (C1.18.4/anti-keratin) were administered intrabronchially into native lungs. Animals receiving anti-MHC class I, but not control Abs, developed marked cellular infiltration around vessels and bronchiole of lung by day 15, followed by epithelial hyperplasia, fibrosis, and occlusion of the distal airways similar to chronic rejection following human lung transplantation. Lungs of mice receiving anti-MHC class I showed increased expression of chemokines, their receptors, and growth factors, and induced IL-17 as well as de novo Abs to self-Ags, K-alpha1 tubulin, and collagen V. IL-17 neutralization by anti-IL-17 resulted in reduction of autoantibody and lesions induced by anti-MHC class I Abs. Thus, our results indicate that Abs to donor MHC can induce autoimmunity, mediated by IL-17, which plays a pivotal role in chronic rejection postlung transplantation. Therefore, approaches to prevent autoimmunity should be considered for the treatment of chronic rejection postlung transplantation.

Indexed as

AnimalsAutoantibodiesAutoimmune DiseasesBinding Sites, AntibodyBronchiolitis ObliteransCell MovementChronic DiseaseFibrosisGraft RejectionH-2 AntigensHyperplasiaImmunity, CellularInterleukin-17Intubation, IntratrachealLung TransplantationMaleAutoantibodiesH-2 AntigensH-2Kb protein, mouseInterleukin-17

Identifiers

PMID19109162
PMCPMC2802821
OpenAlexW1623169079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.